El Salvador Pharmaceuticals & Healthcare Q1 2021

El Salvador Pharmaceuticals & Healthcare Q1 2021

Key View:

The pharmaceutical market in El Salvador remains mostly unattractive for multinational drugmakers, as the country'ssmall market size, low per capita spending and weak security environment continue to pose barriers for investment. Despite this,opportunities exist in specific therapeutic niches, such as oncology, where companies that support El Salvador in addressing itscancer crisis will be rewarded with a position in a growing market. Though Bukele has significantly increased funding to the Ministryof Health to combat Covid-19, ongoing allegations of corruption and a major recession in El Salvador will undermine governmentsupport going forward.


Key View
El Salvador Pharmaceuticals & Healthcare Covid-19 Impact
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Healthcare Market Forecast
Pharmaceutical Trade Forecast
Industry Risk/Reward Index
Americas Innovative Pharmaceuticals Risk/Reward Index
Innovative Pharmaceuticals Risk/Reward Index
Regulatory Development
Market Overview
Competitive Landscape
Company Profile
Ancalmo Internacional
El Salvador
Pharmaceuticals & Healthcare Glossary
Pharmaceuticals & Healthcare Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook